Your browser doesn't support javascript.
loading
Persistent polyomavirus-associated nephropathy in a patient with GvHD and treatment with the JAK1/2 inhibitor ruxolitinib.
Fante, Matthias A; Holler, Ernst; Schmidt, Barbara; Wolff, Daniel; Ehrl, Yvonne; Plentz, Annelie.
Afiliação
  • Fante MA; Department of Hematology and Oncology, Internal Medicine III, University Medical Center, Regensburg, Germany. matthias.fante@ukr.de.
  • Holler E; Department of Hematology and Oncology, Internal Medicine III, University Medical Center, Regensburg, Germany.
  • Schmidt B; Institute of Medical Microbiology and Hygiene, Department of Virology, University of Regensburg, Regensburg, Germany.
  • Wolff D; Institute of Clinical Microbiology and Hygiene, Clinical Virology and Infection Immunology, University Medical Center, Regensburg, Germany.
  • Ehrl Y; Department of Hematology and Oncology, Internal Medicine III, University Medical Center, Regensburg, Germany.
  • Plentz A; Department of Nephrology, Internal Medicine II, University Medical Center, Regensburg, Germany.
Bone Marrow Transplant ; 54(5): 762-764, 2019 05.
Article em En | MEDLINE | ID: mdl-30349038

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Polyomavirus / Infecções por Polyomavirus / Janus Quinase 1 / Janus Quinase 2 / Doença Enxerto-Hospedeiro / Nefropatias Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Polyomavirus / Infecções por Polyomavirus / Janus Quinase 1 / Janus Quinase 2 / Doença Enxerto-Hospedeiro / Nefropatias Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article